Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
9.46
-0.09 (-0.94%)
At close: Oct 3, 2025, 4:00 PM EDT
9.48
+0.02 (0.21%)
After-hours: Oct 3, 2025, 7:57 PM EDT
Novavax Market Cap
Novavax has a market cap or net worth of $1.54 billion as of October 3, 2025. Its market cap has decreased by -25.77% in one year.
Market Cap
1.54B
Enterprise Value
1.15B
1-Year Change
-25.77%
Ranking
Category
Stock Price
$9.46
Market Cap Chart
Since December 1, 1998, Novavax's market cap has increased from $25.70M to $1.54B, an increase of 5,878.63%. That is a compound annual growth rate of 16.45%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 2, 2025 | 1.55B | 20.44% |
Dec 31, 2024 | 1.29B | 125.87% |
Dec 29, 2023 | 570.20M | -29.34% |
Dec 30, 2022 | 807.00M | -92.54% |
Dec 31, 2021 | 10.82B | 52.38% |
Dec 31, 2020 | 7.10B | 6,609.55% |
Dec 31, 2019 | 105.80M | -84.98% |
Dec 31, 2018 | 704.40M | 81.13% |
Dec 29, 2017 | 388.90M | 13.78% |
Dec 30, 2016 | 341.80M | -84.90% |
Dec 31, 2015 | 2.26B | 60.10% |
Dec 31, 2014 | 1.41B | 32.47% |
Dec 31, 2013 | 1.07B | 281.83% |
Dec 31, 2012 | 279.60M | 92.96% |
Dec 30, 2011 | 144.90M | -46.33% |
Dec 31, 2010 | 270.00M | 8.56% |
Dec 31, 2009 | 248.70M | 90.28% |
Dec 31, 2008 | 130.70M | -36.71% |
Dec 31, 2007 | 206.50M | -18.35% |
Dec 29, 2006 | 252.90M | 33.74% |
Dec 30, 2005 | 189.10M | 46.70% |
Dec 31, 2004 | 128.90M | -28.82% |
Dec 31, 2003 | 181.10M | 182.53% |
Dec 31, 2002 | 64.10M | -80.46% |
Dec 31, 2001 | 328.10M | 97.53% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 753.98B |
Johnson & Johnson | 454.31B |
AbbVie | 413.22B |
UnitedHealth Group | 326.22B |
Novo Nordisk | 264.73B |
AstraZeneca | 264.35B |
Novartis AG | 256.18B |
Abbott Laboratories | 234.25B |